Fragment, Modified GRF, Ipamorelin 12mg (Blend)
$100.00
PRODUCT SHORT DESCRIPTION
The Fragment, Modified GRF, and Ipamorelin formulation delivers an advanced, triple-action 12mg (12000mcg) research blend combining three synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility, and parallel lipid metabolism pathways.
Fragment, Modified GRF, and Ipamorelin 12mg Blend is an advanced triple-action research peptide formulation offered at ≥98% purity by The Peptide Store. This precisely engineered 12,000mcg lyophilized blend combines three synergistic synthetic peptides in a single vial, designed exclusively for scientific investigation of dual-receptor somatotroph coordination, optimized growth hormone pulsatility, and parallel lipid metabolism pathways. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Product Overview
The Fragment, Modified GRF, Ipamorelin 12mg Blend available at The Peptide Store represents a sophisticated multi-pathway research platform engineered for laboratories investigating complex peptide synergy along the mammalian growth hormone axis and peripheral metabolic systems. Rather than isolating a single receptor pathway, this advanced blend unifies three distinct synthetic peptide architectures into one precisely calibrated formulation, providing endocrinology, metabolic biochemistry, and molecular biology research teams with a reliable vehicle to map synchronized cellular signaling, receptor cross-talk, and downstream adipose tissue transcription dynamics.
Peptide Structure & Amino Acid Sequence
This blend incorporates three structurally distinct synthetic peptides, each contributing a unique mechanistic profile:
- HGH Fragment 176-191: A 16-amino acid C-terminal segment of the human growth hormone sequence, selectively associated with lipolytic signaling pathways in preclinical metabolic research models.
- Modified GRF (1-29) — Mod GRF: A tetra-substituted analogue of endogenous GHRH(1-29), engineered with strategic amino acid modifications at positions 2, 8, 15, and 27 to confer enhanced enzymatic stability and extended receptor engagement at the GHRH receptor (GHRHR).
- Ipamorelin: A pentapeptide growth hormone secretagogue receptor 1a (GHS-R1a) agonist with high selectivity, minimal off-target ghrelin-axis activity, and a well-characterized pulsatile GH release profile in preclinical somatotroph research.
Together, these three peptides form a coordinated somatotropic matrix that enables researchers to simultaneously probe GHRHR and GHS-R1a activation within a single experimental framework.
Chemical & Physical Characteristics
- Blend Total Mass: 12mg (12,000mcg) per vial
- Physical Form: Lyophilized white to off-white powder
- Solubility: Soluble in aqueous buffers under standard laboratory conditions
- Molecular Architecture: Three-component synthetic peptide blend; each component is a linear, amidated or free-acid peptide depending on sequence terminus
- Storage Stability: Optimized for long-term integrity under recommended cold-chain conditions
Purity & Analytical Verification (HPLC & MS)
Every batch of the Fragment, Modified GRF, Ipamorelin 12mg Blend supplied by The Peptide Store is independently verified to achieve a minimum purity of ≥98% per individual peptide component. Analytical verification is conducted using reverse-phase high-performance liquid chromatography (RP-HPLC) and confirmed by mass spectrometry (MS) to validate molecular weight accuracy, sequence integrity, and absence of significant impurity peaks across all three components. Certificate of Analysis (CoA) documentation is available upon request, ensuring full analytical traceability for research compliance records.
Quality Control & Lyophilization Integrity
The Peptide Store applies rigorous quality control protocols throughout production and packaging. Each vial undergoes vacuum-sealed lyophilization to remove residual moisture, preserve peptide tertiary conformation, and extend shelf-life under appropriate storage conditions. Lyophilization integrity is validated through moisture content testing, and each batch is assigned a unique lot number for full traceability. Only vials meeting all internal QC benchmarks are released for research distribution.
Safety, Handling & Laboratory Precautions
This product is intended exclusively for qualified researchers operating within appropriately equipped laboratory environments. Standard laboratory personal protective equipment (PPE) — including gloves, eye protection, and lab coats — should be worn during handling. Researchers should consult applicable institutional biosafety guidelines and relevant Safety Data Sheet (SDS) documentation prior to use. This blend is not approved for any in vivo, clinical, diagnostic, or consumptive application.
Reconstitution, Packaging & Storage
The Fragment, Modified GRF, Ipamorelin 12mg Blend is supplied as a lyophilized powder in a sealed, sterile-grade research vial. Reconstitution should be performed using appropriate laboratory-grade solvents as determined by the receiving research institution’s standard operating procedures. Upon receipt, store lyophilized vials at -20°C for long-term preservation. Once reconstituted, store at 2–8°C and use within the timeframe consistent with institutional research protocols. Avoid repeated freeze-thaw cycles to maintain peptide integrity.
Intended Research Use & Market Positioning
This blend is positioned as a premium multi-component research tool for advanced somatotropic axis studies. Key investigative applications in preclinical research include: dual-receptor agonism studies (GHRHR + GHS-R1a), pulsatile growth hormone secretion modeling, lipid metabolism and adipose tissue signaling research, and receptor cross-talk mapping in endocrine cell lines. The Peptide Store supplies this formulation to academic institutions, contract research organizations (CROs), and licensed preclinical research laboratories seeking high-purity, analytically verified peptide blends.
Ordering, Availability & Fulfillment
The Fragment, Modified GRF, Ipamorelin 12mg Blend is available to buy online directly through The Peptide Store. Researchers can order now with confidence, knowing each vial is backed by ≥98% purity certification and full CoA documentation. The Peptide Store offers competitive best-price fulfillment, secure checkout, and reliable dispatch to qualified research institutions. For bulk order inquiries or institutional purchasing, contact our research sales team directly.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The Fragment, Modified GRF, Ipamorelin 12mg Blend is sold exclusively as a laboratory research reagent. The Peptide Store makes no claims regarding therapeutic efficacy, safety for administration, or suitability for any application beyond controlled preclinical research. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international regulations governing the acquisition, handling, and use of synthetic research peptides.
Related products
CJC-1295 (No DAC), GHRP-2 10mg (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC and GHRP-2 formulation delivers an advanced, dual-action 10mg (10000mcg) research blend combining two synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and growth hormone secretagogue receptor mechanics.
CJC-1295 (No DAC), GHRP-6 10mg (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC and GHRP-6 formulation delivers an advanced, dual-action 10mg (10000mcg) research blend combining two synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and growth hormone secretagogue receptor mechanics.
CJC-1295 no DAC 2mg (Mod GRF 1-29)
PRODUCT SHORT DESCRIPTION
CJC-1295 No DAC 2mg (Modified GRF 1-29) is a premium, high-purity synthetic peptide analogue engineered for advanced somatotropic signaling, neuroendocrine regulation, and pharmacokinetic stability research. This 2mg configuration provides a highly stable biochemical tool for investigating GHRH receptor affinity, adenylate cyclase activation, and pulsatile growth hormone mechanics.
GHRP-2 (5mg x 10), CJC-1295 no DAC (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-2 alongside ten 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, maximum growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
GHRP-6 (5mg x 10) Ipamorelin (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-6 and Ipamorelin combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-6 alongside ten 5mg vials of Ipamorelin. This 5000mcg per vial configuration is engineered strictly for investigating ghrelin receptor subtype mechanics, comparative GHS-R1a agonist kinetics, and amplified growth hormone (GH) secretion profiles.
GHRP-6 10mg
PRODUCT SHORT DESCRIPTION
GHRP-6 10mg is a premium, high-purity synthetic hexapeptide engineered for advanced somatotropic and metabolic axis evaluation. This 10mg formulation provides a highly potent biochemical tool for investigating GHS-R1a receptor kinetics, intracellular signaling mechanisms, and pulsatile growth hormone (GH) transcription.
IGF-1 LR3 1mg
PRODUCT SHORT DESCRIPTION
IGF-1 LR3 1mg is a premium, high-potency synthetic 83-amino-acid analog of human Insulin-like Growth Factor-1. Featuring an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, this 1000mcg configuration is engineered strictly for investigating sustained somatotropic signaling and uninhibited receptor binding kinetics.
Ipamorelin (2mg x 10), CJC-1295 no DAC (2mg x 10)
PRODUCT SHORT DESCRIPTION
The Ipamorelin and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 2mg vials of Ipamorelin alongside ten 2mg vials of CJC-1295 No DAC. This configuration is engineered strictly for investigating dual-receptor somatotroph coordination, amplified growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.

Reviews
There are no reviews yet.